Skip Navigation

Find a Doctor

Find a Researcher

Researchers

Rajarsi Mandal, M.D.

Photo of Dr. Rajarsi Mandal, M.D.
  • Assistant Professor of Otolaryngology - Head and Neck Surgery

Expertise

Benign Tumors of the Head and Neck, Head and Neck Cancers, Head and Neck Surgery, Head and Neck Tumors, Laryngeal Cancer, Oral Cancers, Salivary Gland Tumors, Skin Cancer of the Head and Neck, Thyroid Masses, Thyroid Surgery, Tonsil Cancer, Transoral robotic surgery (TORS) ...read more

Request an Appointment

Insurance Information

Maryland

443-997-6467
Request Appointment

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Outpatient Center

Appointment Phone: 443-997-6467
601 N. Caroline St. 6th Floor Baltimore, MD 21287 map

Background

Dr. Mandal is a head and neck cancer surgeon with expertise in the surgical treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, thyroid and parathyroid glands, and skin. 

He also serves as Director of the Head and Neck Cancer Immunotherapy Research Program at the Johns Hopkins University/Bloomberg-Kimmel Institute for Cancer Immunotherapy. He has specific interest in the treatment and research of advanced head and neck cancers with immune-based therapies. His research efforts involve understanding the genetic and immunologic basis for response to immunotherapy to better personalize immunotherapy cancer care for patients with head and neck cancer.

...read more

Titles

  • Assistant Professor of Otolaryngology - Head and Neck Surgery

Departments / Divisions

Education

Degrees

  • MD, The Ohio State University Wexner Medical Center (2010)

Residencies

  • University of Pittsburgh Medical Center / Otolaryngology (2015)

Fellowships

  • Memorial Sloan-Kettering Cancer Center (2018)

Board Certifications

  • American Board of Otolaryngology - Head and Neck Surgery / Otolaryngology (2016)

Research & Publications

Lab

Dr. Mandal serves as Director of the Head and Neck Cancer Immunotherapy Research Program at Johns Hopkins University/Bloomberg-Kimmel Institute for Cancer Immunotherapy. His laboratory research efforts focus on the treatment of advanced head and neck cancers with immune-based therapies. His efforts entail understanding the genetic and immunological basis for response to immunotherapy to better personalize immunotherapy cancer care for patients with head and neck cancer.

Selected Publications

Mandal R, Samstein RM, Lee KW, Havel JJ, Wang H, Krishna C, et al. Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science. 2019;364(6439):485-91

Mandal R, Senbabaoglu Y, Desrichard A, Havel J, Dalin M, Riaz N, Lee K, Ganly I, Hakimi A, Chan T, Morris L. The Head and Neck Cancer Immune Landscape and its Immunotherapeutic Implications. JCI Insight. 2016

Mandal R, Chan TA, Personalized Oncology Meets Immunology: The Path toward Prescision Immunotherapy. Cancer Discovery. 2016

Mandal R, Duvvuri U, Ferris RL, Kaffenberger TM, Choby GW, Kim S. Analysis of post-transoral robotic assisted surgery hemorrhage: frequency, outcomes and prevention. Head Neck. 2015

Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, Hode FS, Martin-Algarra S, Mandal R, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017;171(4):934-49 e15.

Activities & Honors

Honors

  • Young Investigator Award, American Society of Clinical Oncology, 2017 - 2018
  • New York Head and Neck Society Proffered Paper Secession Award, New Your Head and Neck Society, 2016

Memberships

  • American Academy of Otolaryngology-Head and Neck Surgery
  • American Society of Clinical Oncology
  • American Head and Neck Society

Videos & Media

Lectures and Presentations

  • The Genomic and Immunologic Determinants of Response to Cancer Immunotherapy
    Presentation, World Congress, Cambridge Healthtech Institute's Fourteenth Annual Biomarkers and Immuno-Oncology World Congress, Boston, MA (06/11/2018)
    Cambridge Healthtech Institute
  • Shaping of Immunotherapy Response by the Cancer Genome
    presentation, Conference, Twenty-fourth Molecular Medicine Tri-conference, San Francisco, California (02/22/2017)
    Memorial Sloan-Kettering Cancer Center
  • Cancer Neoantigens and Their Role as Predictive Biomarkers for Cancer Immunotherapy
    lecture, Conference, Second Annual Diagnostics to Guide Cancer Immunotherapy Conference, Washington, DC (08/24/2016)
    Cambridge Healthtech Institute
  • The Genomic and Immunologic Determinants of Response to Head and Neck Cancer Immunotherapy
    presentation, conference, Third Annual Biomarkers for Cancer Immunology and Combinations, Washington, DC (08/15/2017)
    Cambridge Healthtech Institute

Recent News Articles and Media Coverage

Tumor Mutations May Predict Response to Immunotherapy Press Release Johns Hopkins Kimmel Cancer Center (5-7-2019) 

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button